Building Our Clinical Hyperbaric Oxygen Chamber
Target Audience
After FDA Clearance
After FDA Clearance
Patient treatments are focused on the 15 currently approved medical conditions that are coded for insurance reimbursements. These treatments can also be applied to numerous off-label conditions that require cash payments and are not permitted in hospital facilities in the USA.
After FDA Clearance
After FDA Clearance
After FDA Clearance
Following FDA clearance of our clinical medical device, the initial focus will be directed at 15 medical specialties. These specialties are already treating patients suffering from ailments and diseases where hyperbaric oxygen therapy has been used successfully with positive results for patients.
Tax Savings - Purchase
Disruptive Business Model
Disruptive Business Model
Internal Revenue Service (IRS) Code 179 applies to capital medical device equipment and specifies that a deduction of up to $1,220,000.00 may be made in the first year of purchase.
Disruptive Business Model
Disruptive Business Model
Disruptive Business Model
RxAir360 Inc. is poised to present the RxAir360 mono-place clinical hyperbaric oxygen chamber as an investment opportunity targeted at physicians. This investment offers the potential for immediate returns, which physicians have yet to have the opportunity to leverage. Physicians treating approved conditions are not required to actively seek new patients for their chambers. This class II medical device represents an innovative approach to expanding medical practices and enhancing patient outcomes.